Cargando…

Serum CXCL5 level is associated with tumor progression in penile cancer

Chemokine (C-X-C motif) ligand 5 is an important regulator of tumor progression in many cancers, and could serve as potential serum cancer biomarker. Our initial analysis identified CXCL5 as a cancer-related gene highly expressed in PC. Patients with PC exhibited markedly higher preoperative serum C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mo, Miao, Li, Yangle, Hu, Xiheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2021
Materias:	Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843497/ https://www.ncbi.nlm.nih.gov/pubmed/33458757 http://dx.doi.org/10.1042/BSR20202133

Ejemplares similares

Serum CXCL13 Level is Associated with Tumor Progression and Unfavorable Prognosis in Penile Cancer
por: Mo, Miao, et al.
Publicado: (2020)

High serum CCL20 is associated with tumor progression in penile cancer
por: Mo, Miao, et al.
Publicado: (2020)

Aberrant CEACAM19 expression is associated with metastatic phenotype in penile cancer
por: Hu, Xiheng, et al.
Publicado: (2019)

Identification of key genes and microRNA regulatory network in development and progression of urothelial bladder carcinoma
por: Mo, Miao, et al.
Publicado: (2021)

CXCL9: evidence and contradictions for its role in tumor progression
por: Ding, Qiang, et al.
Publicado: (2016)

RGS20 Promotes Tumor Progression through Modulating PI3K/AKT Signaling Activation in Penile Cancer
por: Shi, Dazun, et al.
Publicado: (2022)

LncRNA SNHG9 is a prognostic biomarker and correlated with immune infiltrates in prostate cancer
por: Li, Chao, et al.
Publicado: (2021)

MEST promotes bladder cancer cell proliferation, migration and invasion via STAT3/Twist-1-mediated EMT
por: Zhao, Cheng, et al.
Publicado: (2020)

Competing endogenous RNA network analysis reveals pivotal ceRNAs in bladder urothelial carcinoma
por: Li, Yangle, et al.
Publicado: (2021)

Long noncoding RNA MAFG-AS1 facilitates bladder cancer tumorigenesis via regulation of miR-143-3p/SERPINE1 axis
por: Sun, Xi, et al.
Publicado: (2020)

Up-regulation of CXCL8 expression is associated with a poor prognosis and enhances tumor cell malignant behaviors in liver cancer
por: Yang, Song, et al.
Publicado: (2020)

Serum CXCL9 Levels Are Associated with Tumor Progression and Treatment Outcome in Patients with Nasopharyngeal Carcinoma
por: Hsin, Li-Jen, et al.
Publicado: (2013)

Perivascular tumor-associated macrophages and their role in cancer progression
por: Bahri, Meriem, et al.
Publicado: (2023)

Serum CXCL5 Detects Early Hepatocellular Carcinoma and Indicates Tumor Progression
por: Laschtowitz, Alena, et al.
Publicado: (2023)

Forkhead Box R2 Knockdown Decreases Chemoresistance to Cisplatin via MYC Pathway in Bladder Cancer
por: Li, Yangle, et al.
Publicado: (2019)

Penile sparing therapy for penile cancer
por: Yao, Henry Han-I, et al.
Publicado: (2020)

The chemokine CXCL13 in lung cancers associated with environmental polycyclic aromatic hydrocarbons pollution
por: Wang, Gui-Zhen, et al.
Publicado: (2015)

ERα-mediated alterations in circ_0023642 and miR-490-5p signaling suppress bladder cancer invasion
por: Wu, Longxiang, et al.
Publicado: (2019)

Plasma CXCL3 Levels Are Associated with Tumor Progression and an Unfavorable Colorectal Cancer Prognosis
por: Cui, Can, et al.
Publicado: (2022)

LncRNA HCP5 Promotes Cell Invasion and Migration by Sponging miR-29b-3p in Human Bladder Cancer
por: Zhao, Cheng, et al.
Publicado: (2020)

Comparison of efficacy between brachytherapy and penectomy in patients with penile cancer: a meta-analysis
por: Hu, Xiheng, et al.
Publicado: (2017)

Association of Baseline Serum Levels of CXCL5 With the Efficacy of Nivolumab in Advanced Melanoma
por: Fujimura, Taku, et al.
Publicado: (2019)

The correlation between tumor-associated macrophage infiltration and progression in cervical carcinoma
por: Guo, Fan, et al.
Publicado: (2021)

Competing‐risks model for predicting the prognosis of penile cancer based on the SEER database
por: Yang, Jin, et al.
Publicado: (2019)

Patterns of Recurrence and Survival After Pelvic Treatment for Locally Advanced Penile Cancer
por: de Vries, Hielke M., et al.
Publicado: (2022)

Modulation of CXCL-8 expression in human melanoma cells regulates tumor growth, angiogenesis, invasion, and metastasis
por: Wu, Sheng, et al.
Publicado: (2012)

Identification of CXCL5 expression as a predictive biomarker associated with response and prognosis of immunotherapy in patients with non‐small cell lung cancer
por: Deng, Jie, et al.
Publicado: (2022)

Pretreatment serum interleukin‐1β, interleukin‐6, and tumor necrosis factor‐α levels predict the progression of colorectal cancer
por: Chang, Pei‐Hung, et al.
Publicado: (2016)

CXCL8, CXCL9, and CXCL10 serum levels increase in syphilitic patients with seroresistance
por: Dong, Xiaoyan, et al.
Publicado: (2021)

CXCL10/CXCR3 signaling contributes to an inflammatory microenvironment and its blockade enhances progression of murine pancreatic precancerous lesions
por: Pandey, Veethika, et al.
Publicado: (2021)

The role of HOPX in normal tissues and tumor progression
por: Liu, Yijun, et al.
Publicado: (2020)

CXCL5: A coachman to drive cancer progression
por: Deng, Jie, et al.
Publicado: (2022)

MicroRNA-183-5p contributes to malignant progression through targeting PDCD4 in human hepatocellular carcinoma
por: Duan, Xiaohui, et al.
Publicado: (2020)

LncRNA NEAT1 promotes glioma cancer progression via regulation of miR-98-5p/BZW1
por: Li, Yabin, et al.
Publicado: (2021)

CTAPIII/CXCL7: a novel biomarker for early diagnosis of lung cancer
por: Du, Qiang, et al.
Publicado: (2018)

An miRNA signature associated with tumor mutation burden in endometrial cancer
por: Zhou, Hongyu, et al.
Publicado: (2020)

Serum CYR61 as a potential biomarker for the diagnosis of esophagogastric junction tumor
por: Chu, Ling-Yu, et al.
Publicado: (2021)

The combination of CXCL9, CXCL10 and CXCL11 levels during primary HIV infection predicts HIV disease progression
por: Yin, Xiaowan, et al.
Publicado: (2019)

What Is the Most Effective Management of the Primary Tumor in Men with Invasive Penile Cancer: A Systematic Review of the Available Treatment Options and Their Outcomes
por: Sakalis, Vasileios I., et al.
Publicado: (2022)

The role of penectomy in penile cancer—evolving paradigms
por: O’Neill, Sarah, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_f3vnke65grf8mn4so5uiu5mm4r